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Abstract
©  The  Author(s)  2017.  Polyelectrolyte-coated  nanoparticles  consisting  of  terbium  and
gadolinium complexes  with  calix[4]arene  tetra-diketone  ligand  were  first  synthesized.  The
antenna effect of the ligand on Tb(III) green luminescence and the presence of water molecules
in the coordination sphere of Gd(III) bring strong luminescent and magnetic performance to the
core-shell nanoparticles. The size and the core-shell morphology of the colloids were studied
using transmission electron microscopy and dynamic light scattering. The correlation between
photophysical and magnetic properties of the nanoparticles and their core composition was
highlighted. The core composition was optimized for the longitudinal relaxivity to be greater
than that of the commercial magnetic resonance imaging (MRI) contrast agents together with
high level of Tb(III)-centered luminescence. The tuning of both magnetic and luminescent output
of nanoparticles is obtained via the simple variation of lanthanide chelates concentrations in the
initial synthetic solution. The exposure of the pheochromocytoma 12 (PC 12) tumor cells and
periphery human blood lymphocytes to nanoparticles results in negligible effect on cell viability,
decreased platelet aggregation and bright coloring, indicating the nanoparticles as promising
candidates for dual magneto-fluorescent bioimaging.
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